Low RAI2 expression is a marker of poor prognosis in breast cancer.
Nishikawa S, Uemoto Y, Kim TS, Hisada T, Kondo N, Wanifuchi-Endo Y, Fujita T, Asano T, Katagiri Y, Terada M, Kato A, Dong Y, Sugiura H, Okuda K, Kato H, Osaga S, Takahashi S, Toyama T.
Nishikawa S, et al.
Breast Cancer Res Treat. 2021 May;187(1):81-93. doi: 10.1007/s10549-021-06176-w. Epub 2021 Mar 29.
Breast Cancer Res Treat. 2021.
PMID: 33782811